Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 358

1.

Preclinical Assessment of Cardiac Valve Substitutes: Current Status and Considerations for Engineered Tissue Heart Valves.

Zhang BL, Bianco RW, Schoen FJ.

Front Cardiovasc Med. 2019 Jun 7;6:72. doi: 10.3389/fcvm.2019.00072. eCollection 2019. Review.

2.

2019 Society for Cardiovascular Pathology Distinguished Achievement Award Recipient -- Gayle L. Winters, M.D.

Schoen FJ, Mitchell RN.

Cardiovasc Pathol. 2019 May 6;42:4-5. doi: 10.1016/j.carpath.2019.04.003. [Epub ahead of print] No abstract available.

PMID:
31153109
3.

Functional remodeling of an electrospun polydimethylsiloxane-based polyether urethane external vein graft support device in an ovine model.

El-Kurdi M, Soletti L, McGrath J, Linhares S, Rousselle S, Greisler H, Edelman E, Schoen FJ.

J Biomed Mater Res A. 2019 May 16. doi: 10.1002/jbm.a.36724. [Epub ahead of print]

PMID:
31094084
4.

Repeated generalized seizures can produce calcified cardiac lesions in DBA/1 mice.

Zhao H, Zhang H, Schoen FJ, Schachter SC, Feng HJ.

Epilepsy Behav. 2019 Jun;95:169-174. doi: 10.1016/j.yebeh.2019.04.010. Epub 2019 May 4.

PMID:
31063933
5.

After 50 Years of Heart Transplants: What Does the Next 50 Years Hold for Cardiovascular Medicine? A Perspective From the International Society for Applied Cardiovascular Biology.

Hutcheson JD, Goergen CJ, Schoen FJ, Aikawa M, Zilla P, Aikawa E, Gaudette GR.

Front Cardiovasc Med. 2019 Feb 14;6:8. doi: 10.3389/fcvm.2019.00008. eCollection 2019.

6.

Nanoparticles targeting extra domain B of fibronectin-specific to the atherosclerotic lesion types III, IV, and V-enhance plaque detection and cargo delivery.

Yu M, Ortega CA, Si K, Molinaro R, Schoen FJ, Leitao RFC, Xu X, Mahmoudi M, Ahn S, Liu J, Saw PE, Lee IH, Brayner MMB, Lotfi A, Shi J, Libby P, Jon S, Farokhzad OC.

Theranostics. 2018 Nov 15;8(21):6008-6024. doi: 10.7150/thno.24365. eCollection 2018.

7.

Morphology and mechanisms of a novel absorbable polymeric conduit in the pulmonary circulation of sheep.

Brugmans M, Serrero A, Cox M, Svanidze O, Schoen FJ.

Cardiovasc Pathol. 2019 Jan - Feb;38:31-38. doi: 10.1016/j.carpath.2018.10.008. Epub 2018 Oct 25.

PMID:
30428421
8.

Early animal model evaluation of an implantable contrast agent to enhance magnetic resonance imaging of arterial bypass vein grafts.

Mitsouras D, Tao M, de Vries MR, Trocha K, Miranda OR, Vemula PK, Ding K, Imanzadeh A, Schoen FJ, Karp JM, Ozaki CK, Rybicki FJ.

Acta Radiol. 2018 Sep;59(9):1074-1081. doi: 10.1177/0284185117753656. Epub 2018 Jan 29.

PMID:
29378421
9.

Reproducible in vitro model for dystrophic calcification of cardiac valvular interstitial cells: insights into the mechanisms of calcific aortic valvular disease.

Cirka HA, Uribe J, Liang V, Schoen FJ, Billiar KL.

Lab Chip. 2017 Feb 28;17(5):814-829. doi: 10.1039/c6lc01226d.

PMID:
28128382
10.

Heart Valve Biomechanics and Underlying Mechanobiology.

Ayoub S, Ferrari G, Gorman RC, Gorman JH, Schoen FJ, Sacks MS.

Compr Physiol. 2016 Sep 15;6(4):1743-1780. doi: 10.1002/cphy.c150048. Review.

11.

Morphology, Clinicopathologic Correlations, and Mechanisms in Heart Valve Health and Disease.

Schoen FJ.

Cardiovasc Eng Technol. 2018 Jun;9(2):126-140. doi: 10.1007/s13239-016-0277-7. Epub 2016 Aug 8. Review.

PMID:
27502286
12.

The pathology and pathobiology of bicuspid aortic valve: State of the art and novel research perspectives.

Mathieu P, Bossé Y, Huggins GS, Della Corte A, Pibarot P, Michelena HI, Limongelli G, Boulanger MC, Evangelista A, Bédard E, Citro R, Body SC, Nemer M, Schoen FJ.

J Pathol Clin Res. 2015 Jun 24;1(4):195-206. doi: 10.1002/cjp2.21. eCollection 2015 Oct.

13.

Heart valve health, disease, replacement, and repair: a 25-year cardiovascular pathology perspective.

Schoen FJ, Gotlieb AI.

Cardiovasc Pathol. 2016 Jul-Aug;25(4):341-352. doi: 10.1016/j.carpath.2016.05.002. Epub 2016 May 10. Review.

PMID:
27242130
14.

Local Application of Leptin Antagonist Attenuates Angiotensin II-Induced Ascending Aortic Aneurysm and Cardiac Remodeling.

Ben-Zvi D, Savion N, Kolodgie F, Simon A, Fisch S, Schäfer K, Bachner-Hinenzon N, Cao X, Gertler A, Solomon G, Kachel E, Raanani E, Lavee J, Kotev Emeth S, Virmani R, Schoen FJ, Schneiderman J.

J Am Heart Assoc. 2016 May 3;5(5). pii: e003474. doi: 10.1161/JAHA.116.003474.

15.

Simulation of early calcific aortic valve disease in a 3D platform: A role for myofibroblast differentiation.

Hjortnaes J, Goettsch C, Hutcheson JD, Camci-Unal G, Lax L, Scherer K, Body S, Schoen FJ, Kluin J, Khademhosseini A, Aikawa E.

J Mol Cell Cardiol. 2016 May;94:13-20. doi: 10.1016/j.yjmcc.2016.03.004. Epub 2016 Mar 17.

16.

In Memoriam Larry L. Hench, Ph.D. 1938 - 2015.

Schoen FJ, Greenspan DC.

J Biomed Mater Res A. 2016 Apr;104(4):819-20. doi: 10.1002/jbm.a.35665. Epub 2016 Feb 14. No abstract available.

PMID:
26801835
17.

Comparative Histopathological Analysis of Mitral Valves in Barlow Disease and Fibroelastic Deficiency.

Hjortnaes J, Keegan J, Bruneval P, Schwartz E, Schoen FJ, Carpentier A, Levine RA, Hagège A, Aikawa E.

Semin Thorac Cardiovasc Surg. 2016 Winter;28(4):757-767. doi: 10.1053/j.semtcvs.2016.08.015. Epub 2016 Sep 5.

18.

Perivascular adipose adiponectin correlates with symptom status of patients undergoing carotid endarterectomy.

Sharma G, Tao M, Ding K, Yu D, King W, Deyneko G, Wang X, Longchamp A, Schoen FJ, Ozaki CK, Semel ME.

Stroke. 2015 Jun;46(6):1696-9. doi: 10.1161/STROKEAHA.114.008468. Epub 2015 May 12.

19.

The power of disruptive technological innovation: Transcatheter aortic valve implantation.

Berlin DB, Davidson MJ, Schoen FJ.

J Biomed Mater Res B Appl Biomater. 2015 Nov;103(8):1709-15. doi: 10.1002/jbm.b.33352. Epub 2014 Dec 24.

PMID:
25545639
20.

Directing valvular interstitial cell myofibroblast-like differentiation in a hybrid hydrogel platform.

Hjortnaes J, Camci-Unal G, Hutcheson JD, Jung SM, Schoen FJ, Kluin J, Aikawa E, Khademhosseini A.

Adv Healthc Mater. 2015 Jan 7;4(1):121-30. doi: 10.1002/adhm.201400029. Epub 2014 Jun 24.

21.

Transcatheter aortic valve implantation: status and challenges.

Fishbein GA, Schoen FJ, Fishbein MC.

Cardiovasc Pathol. 2014 Mar-Apr;23(2):65-70. doi: 10.1016/j.carpath.2013.10.001. Epub 2013 Oct 8. Review.

PMID:
24183003
22.

Mechanisms of calcification in aortic valve disease: role of mechanokinetics and mechanodynamics.

Merryman WD, Schoen FJ.

Curr Cardiol Rep. 2013 May;15(5):355. doi: 10.1007/s11886-013-0355-5. Review.

23.

2013 Society for Cardiovascular Pathology Distinguished Achievement Award recipient - Michael A. Gimbrone, Jr., M.D.

Schoen FJ.

Cardiovasc Pathol. 2013 Mar-Apr;22(2):115-6. doi: 10.1016/j.carpath.2012.12.003. Epub 2013 Jan 12. No abstract available.

PMID:
23318028
24.

An initial evaluation of analyser-based phase-contrast X-ray imaging of carotid plaque microstructure.

Appel AA, Chou CY, Larson JC, Zhong Z, Schoen FJ, Johnston CM, Brey EM, Anastasio MA.

Br J Radiol. 2013 Jan;86(1021):20120318. doi: 10.1259/bjr.20120318.

25.

Practical Approach to the Evaluation of Prosthetic Mechanical and Tissue Replacement Heart Valves.

VanderLaan PA, Padera RF, Schoen FJ.

Surg Pathol Clin. 2012 Jun;5(2):353-69. doi: 10.1016/j.path.2012.03.002. Epub 2012 May 3.

PMID:
26838108
26.

In memoriam: Jack L. Titus, M.D., Ph.D., 1926–2011.

Schoen FJ.

Cardiovasc Pathol. 2012 Jan-Feb;21(1):62-4. No abstract available.

PMID:
22263229
27.

2011 panel on developing a biomaterials curriculum.

Reichert WM, Harris TR, Lemons J, Mikos AG, Puleo DA, Schoen FJ, Temenoff JS.

J Biomed Mater Res A. 2012 Mar;100(3):802-16. doi: 10.1002/jbm.a.33242. Epub 2012 Jan 11. Review.

PMID:
22238222
28.

Calcific aortic valve disease: not simply a degenerative process: A review and agenda for research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group. Executive summary: Calcific aortic valve disease-2011 update.

Rajamannan NM, Evans FJ, Aikawa E, Grande-Allen KJ, Demer LL, Heistad DD, Simmons CA, Masters KS, Mathieu P, O'Brien KD, Schoen FJ, Towler DA, Yoganathan AP, Otto CM.

Circulation. 2011 Oct 18;124(16):1783-91. doi: 10.1161/CIRCULATIONAHA.110.006767. Review. No abstract available.

29.

Mechanisms of function and disease of natural and replacement heart valves.

Schoen FJ.

Annu Rev Pathol. 2012;7:161-83. doi: 10.1146/annurev-pathol-011110-130257. Epub 2011 Sep 19. Review.

PMID:
21942526
30.

Triglycidyl amine crosslinking combined with ethanol inhibits bioprosthetic heart valve calcification.

Connolly JM, Bakay MA, Alferiev IS, Gorman RC, Gorman JH 3rd, Kruth HS, Ashworth PE, Kutty JK, Schoen FJ, Bianco RW, Levy RJ.

Ann Thorac Surg. 2011 Sep;92(3):858-65. doi: 10.1016/j.athoracsur.2011.04.104.

31.

Heart valve tissue engineering: quo vadis?

Schoen FJ.

Curr Opin Biotechnol. 2011 Oct;22(5):698-705. doi: 10.1016/j.copbio.2011.01.004. Epub 2011 Feb 10. Review.

PMID:
21315575
32.

Three-dimensional quantitative micromorphology of pre- and post-implanted engineered heart valve tissues.

Eckert CE, Mikulis BT, Gottlieb D, Gerneke D, LeGrice I, Padera RF, Mayer JE, Schoen FJ, Sacks MS.

Ann Biomed Eng. 2011 Jan;39(1):205-22. doi: 10.1007/s10439-010-0162-8. Epub 2010 Sep 18.

33.

Clear cells in the atrioventricular valves of infants with severe human mucopolysaccharidosis (Hurler syndrome) are activated valvular interstitial cells.

Braunlin E, Tolar J, Mackey-Bojack S, Masinde T, Krivit W, Schoen FJ.

Cardiovasc Pathol. 2011 Sep-Oct;20(5):315-21. doi: 10.1016/j.carpath.2010.06.004. Epub 2010 Jul 9.

PMID:
20619689
34.

Introduction to congenital heart disease articles in Cardiovascular Pathology.

Schoen FJ.

Cardiovasc Pathol. 2010 Sep-Oct;19(5):257-8. doi: 10.1016/j.carpath.2010.04.008. Epub 2010 Jul 3. No abstract available.

PMID:
20598912
35.

Cardiovascular pathology: maturation of a discipline and the Society for Cardiovascular Pathology.

Schoen FJ.

Cardiovasc Pathol. 2010 Jul-Aug;19(4):198-200. doi: 10.1016/j.carpath.2010.02.007. Epub 2010 Apr 24.

PMID:
20456983
36.

Hemodynamic environments from opposing sides of human aortic valve leaflets evoke distinct endothelial phenotypes in vitro.

Weinberg EJ, Mack PJ, Schoen FJ, García-Cardeña G, Kaazempur Mofrad MR.

Cardiovasc Eng. 2010 Mar;10(1):5-11. doi: 10.1007/s10558-009-9089-9.

37.

AECVP and SCVP 2009 recommendations for training in cardiovascular pathology.

Thiene G, Veinot JP, Angelini A, Baandrup UT, Basso C, Bruneval P, Buja LM, Butany J, d'Amati G, de Gouveia RH, Fallon JT, Fishbein MC, Gallagher PJ, Kholova I, Leone O, McManus B, Rodriguez ER, Schoen FJ, Sheppard MN, Stone JR, van der Wal AC, Winters GL; Association for European Cardiovascular Pathology and Society for Cardiovascular Pathology Task Force on Training in Cardiovascular Pathology.

Cardiovasc Pathol. 2010 May-Jun;19(3):129-35. doi: 10.1016/j.carpath.2009.12.001. Epub 2010 Jan 13. Review.

PMID:
20071198
38.

Endothelial progenitor cells as a sole source for ex vivo seeding of tissue-engineered heart valves.

Sales VL, Mettler BA, Engelmayr GC Jr, Aikawa E, Bischoff J, Martin DP, Exarhopoulos A, Moses MA, Schoen FJ, Sacks MS, Mayer JE Jr.

Tissue Eng Part A. 2010 Jan;16(1):257-67. doi: 10.1089/ten.TEA.2009.0424.

39.

SnapShot: calcification of bioprosthetic heart valves.

Schoen FJ, Levy RJ.

Biomaterials. 2009 Sep;30(26):4445-6. No abstract available.

PMID:
19623686
40.

A computational model of aging and calcification in the aortic heart valve.

Weinberg EJ, Schoen FJ, Mofrad MR.

PLoS One. 2009 Jun 18;4(6):e5960. doi: 10.1371/journal.pone.0005960.

41.

Bioengineering challenges for heart valve tissue engineering.

Sacks MS, Schoen FJ, Mayer JE.

Annu Rev Biomed Eng. 2009;11:289-313. doi: 10.1146/annurev-bioeng-061008-124903. Review.

PMID:
19413511
42.

Functional collagen fiber architecture of the pulmonary heart valve cusp.

Joyce EM, Liao J, Schoen FJ, Mayer JE Jr, Sacks MS.

Ann Thorac Surg. 2009 Apr;87(4):1240-9. doi: 10.1016/j.athoracsur.2008.12.049.

43.

Evolving concepts of cardiac valve dynamics: the continuum of development, functional structure, pathobiology, and tissue engineering.

Schoen FJ.

Circulation. 2008 Oct 28;118(18):1864-80. doi: 10.1161/CIRCULATIONAHA.108.805911. Review.

PMID:
18955677
44.

Programmed death ligand 1 regulates a critical checkpoint for autoimmune myocarditis and pneumonitis in MRL mice.

Lucas JA, Menke J, Rabacal WA, Schoen FJ, Sharpe AH, Kelley VR.

J Immunol. 2008 Aug 15;181(4):2513-21.

45.

Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib.

Chu TF, Rupnick MA, Kerkela R, Dallabrida SM, Zurakowski D, Nguyen L, Woulfe K, Pravda E, Cassiola F, Desai J, George S, Morgan JA, Harris DM, Ismail NS, Chen JH, Schoen FJ, Van den Abbeele AD, Demetri GD, Force T, Chen MH.

Lancet. 2007 Dec 15;370(9604):2011-9.

46.

Healing and remodeling of bioengineered pulmonary artery patches implanted in sheep.

Mendelson K, Aikawa E, Mettler BA, Sales V, Martin D, Mayer JE, Schoen FJ.

Cardiovasc Pathol. 2007 Sep-Oct;16(5):277-82. Epub 2007 Jun 21.

PMID:
17868878
47.

Engineering complex tissues.

Mikos AG, Herring SW, Ochareon P, Elisseeff J, Lu HH, Kandel R, Schoen FJ, Toner M, Mooney D, Atala A, Van Dyke ME, Kaplan D, Vunjak-Novakovic G.

Tissue Eng. 2006 Dec;12(12):3307-39. Review.

48.

Heart valve tissue engineering: concepts, approaches, progress, and challenges.

Mendelson K, Schoen FJ.

Ann Biomed Eng. 2006 Dec;34(12):1799-819. Epub 2006 Oct 12. Review.

50.

Human pulmonary valve progenitor cells exhibit endothelial/mesenchymal plasticity in response to vascular endothelial growth factor-A and transforming growth factor-beta2.

Paruchuri S, Yang JH, Aikawa E, Melero-Martin JM, Khan ZA, Loukogeorgakis S, Schoen FJ, Bischoff J.

Circ Res. 2006 Oct 13;99(8):861-9. Epub 2006 Sep 14.

Supplemental Content

Loading ...
Support Center